Oral Melatonin in Critically Ill High-risk Patients
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
Sleep disruptions are extremely common in high-risk critically ill patients. The
investigators want to analyse oral melatonin potentialities as a sedative and a free-radicals
scavenger for critically ill patients, and secondarily for preventing Delirium during their
ICU stay and post-traumatic stress disorders after ICU discharge.